logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Entasis Therapeutics, Inc.


USPTO Granted Patents = 11



Trademarks = 4

Forward Citations = 19

Loading Chart...
Loading Chart...

34 inventors (with patents filed for the assignee):

goldMedal Thomas Francois Durand-Reville (6 out of 6 patents)

silverMedal Janelle Comita-Prevoir (4 out of 4 patents)

bronzeMedal Ruben Alberto Tommasi (4 out of 19 patents)

4.  Satenig Guler (3 out of 3 patents)

5.  Jeroen Cunera Verheijen (3 out of 15 patents)

6.  Gregory Steven Basarab (3 out of 11 patents)

7.  Madhusudhan Reddy Gowravaram (3 out of 7 patents)

8.  Sheila Irene Hauck (3 out of 14 patents)

9.  Fei Zhou (3 out of 11 patents)

10.  Bolin Geng (2 out of 10 patents)

11.  Neil Bifulco (2 out of 17 patents)

12.  Jan Romero (2 out of 2 patents)

13.  Xiaoyun Wu (2 out of 5 patents)

14.  Jing Zhang (2 out of 2 patents)

15.  Hoan Huynh (2 out of 10 patents)


11 patents:

1. 12396984 - Managing microbial dysbiosis with temocillin (2025-08-26),
2. 11046694 - Compounds and methods for treating bacterial infections (2021-06-29),
3. 10800778 - Beta-lactamase inhibitor compounds (2020-10-13),
4. 10376499 - Combination therapy for treatment of resistant bacterial infections (2019-08-13),
5. 10238661 - Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections (2019-03-26),
6. 9968593 - Combination therapy for treatment of resistant bacterial infections (2018-05-15),
7. 9839641 - Compounds and methods for treating bacterial infections (2017-12-12),
8. 9623014 - β-lactamase inhibitor compounds (2017-04-18),
9. 9540394 - Compounds and methods for treating bacterial infections (2017-01-10),
10. 9309245 - Beta-lactamase inhibitor compounds (2016-04-12),
11. 9187495 - Compounds and methods for treating bacterial infections (2015-11-17),
Entasis Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. The company's pipeline includes innovative treatments targeting drug-resistant bacteria, with a mission to address the growing threat of antibiotic resistance.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

11 Patents

#107 in Waltham, MA

#1,616 in Massachusetts

#26,752 in US

#50,255 in the World

...
Waltham, MA, United States of America

Entasis Therapeutics, Inc.

Forward Citations = 19

34 inventors:

goldMedal Thomas Francois Durand-Reville (6 out of 6 patents)

silverMedal Janelle Comita-Prevoir (4 out of 4 patents)

bronzeMedal Ruben Alberto Tommasi (4 out of 19 patents)

4.  Satenig Guler (3 out of 3 patents)

5.  Jeroen Cunera Verheijen (3 out of 15 patents)

Please report any incorrect information to support@idiyas.com
Loading…